If you have been reading about ESI-MS and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2025-08-18. Numbers and descriptions here follow the published literature rather than marketing material.
Activity is mediated mainly through the growth hormone secretagogue receptor, now generally called the ghrelin receptor or GHS-R1a. Binding at this G-protein-coupled receptor triggers phospholipase C signaling, calcium mobilization, and release of growth hormone from pituitary somatotrophs. Reports describe less pronounced stimulation of adrenocorticotropic hormone and prolactin compared with earlier secretagogues such as hexarelin or GHRP-6. Selectivity figures vary between assay systems, so the degree of separation from other secretagogues is an area of ongoing comparison rather than a fixed constant.
In animal and early human studies, ipamorelin produces pulsatile growth hormone release and a secondary rise in insulin-like growth factor 1. The magnitude and duration of that rise depend on route, sampling schedule, and the baseline endocrine state of the subject. Whether repeated exposure alters the response over time is not firmly settled, since some reports describe stable pulsatility while others note attenuation. Most published data come from small samples, which limits the strength of any general claim about long-term behavior.
One distinguishing feature reported in animal studies is selectivity. Ipamorelin stimulated growth hormone release with limited elevation of adrenocorticotropic hormone or cortisol compared with earlier secretagogues such as GHRP-6. This pattern has been described as more selective for the growth hormone axis. The finding comes mainly from preclinical work, and the degree to which it holds across species and doses is not fully settled. Reports also describe effects on gastric motility in animal models, suggesting activity outside the pituitary, though the clinical relevance of this observation is uncertain.
Ipamorelin is a synthetic pentapeptide that acts on the growth hormone secretagogue receptor, also known as the ghrelin receptor. Its sequence contains five amino acid residues, including a non-natural residue that increases stability against enzymatic breakdown. The compound was developed in the 1990s as part of research into small peptides that stimulate pituitary hormone release. Unlike larger protein hormones, it can be produced by solid-phase peptide synthesis and characterized by standard analytical methods.
At the receptor level, ipamorelin binds GHS-R1a and triggers signaling through Gq-coupled pathways. Activation leads to calcium release and downstream effects in pituitary somatotroph cells. These events promote the release of growth hormone into circulation. The response depends on the presence of the receptor and on the physiological state of the animal or tissue studied. Because the receptor is also found in other tissues, effects beyond the pituitary have been examined in laboratory models, though the extent of those effects remains an area of ongoing study.
| Property | Value | Notes |
|---|---|---|
| Peptide class | Synthetic pentapeptide | GHS-R1a agonist family |
| Receptor target | Ghrelin receptor (GHS-R1a) | G-protein-coupled receptor |
| Sequence length | Five amino acid residues | Includes non-natural residues |
| Primary reported output | Pulsatile growth hormone release | Observed in animal and early human work |
| Molecular formula | C38H49N9O5 | Corresponds to roughly 711.9 g/mol |
Identity and purity are assessed by complementary methods rather than a single test. Reversed-phase high-performance liquid chromatography separates the peptide from related impurities and reports a percentage purity. Mass spectrometry, most often with electrospray ionization, confirms the expected molecular mass and detects sequence-related variants. Amino acid analysis can verify composition, while water content and residual counterion measurements support the mass balance of a batch. Stability studies under accelerated conditions are used to estimate shelf life, though such estimates carry uncertainty for long-term storage.
Material supplied for research use is normally a white to off-white lyophilized powder. The solid is hygroscopic and is handled in a low-humidity environment to limit water uptake. Bulk quantities are frequently shipped in sealed vials under inert gas. Once reconstituted in water or a neutral buffer, the solution is less stable than the dry powder and is usually divided into single-use aliquots.
At the molecular level, ipamorelin acts as an agonist at the growth hormone secretagogue receptor, also called the ghrelin receptor or GHS-R1a. Binding to this receptor on pituitary somatotroph cells triggers a signaling cascade that leads to growth hormone release. The effect is mediated through phospholipase C and calcium mobilization rather than through the cyclic AMP pathway used by growth hormone releasing hormone. The two pathways are complementary, and combined stimulation produces a larger response than either alone.
Compared with other secretagogues such as GHRP-2, GHRP-6, and hexarelin, ipamorelin is described as more selective. Published animal work reports little or no increase in adrenocorticotropic hormone, cortisol, or prolactin at doses that release growth hormone. This selectivity is the property most often cited in the research literature. Whether the same profile holds across species and dosing schedules remains an open question, since human data are limited and come largely from small studies.
Ipamorelin is a synthetic pentapeptide that belongs to the growth hormone secretagogue family. Its sequence is Aib-His-D-2-Nal-D-Phe-Lys-NH2, and its molecular mass is approximately 711.9 daltons. The compound was described in the late 1990s by researchers seeking molecules that release growth hormone with fewer side effects than earlier secretagogues. It is a laboratory and research compound, not an approved medicine in most jurisdictions.
=== Long-acting === Long-acting insulin analogues are designed to provide continuous basal insulin coverage for up to 24 hours, with the exception of ultra-long-acting analogues, which work for up to a week. These include insulin glargine, insulin detemir, insulin degludec, and insulin icodec, which have been modified through amino acid substitutions and fatty acid conjugation to alter their subcutaneous absorption and extend their duration of action. A key feature of long-acting insulin analogues is reversible albumin binding and di-hexamer formation, which slow insulin dissociation and provide a more stable pharmacokinetic and pharmacodynamic profile, reducing glycemic fluctuations and nocturnal hypoglycemia. Insulin glargine (100 U/mL), first approved by the US Food and Drug Administration (FDA) in 2000 and marketed as Lantus, forms zinc-mediated hexamer aggregates after injection, resulting in a slow insulin release. In 2015, a higher-concentration formulation (300 U/mL), marketed as Toujeo, was introduced, offering up to 36-hour coverage and a lower risk of nocturnal hypoglycemia. Insulin detemir, approved in 2005 as Levemir, features a C14 fatty acid modification at lysine B29, promoting di-hexamer formation and albumin binding for an extended duration. While effective, insulin detemir often requires twice-daily dosing for optimal glycemic control.
The commission noted "numerous cases of illegal detention of civilians, arbitrary arrests, abduction and taking of hostages, mostly committed by South Ossetian forces and other South Ossetian armed groups." The commission concluded: "The Russian authorities and the South Ossetian authorities failed overwhelmingly to take measures to maintain law and order and ensure the protection of the civilian population as required under IHL and HRL." The commission noted that "some violations of IHL and HRL during the conflict and its aftermath were motivated by referring to “thousands of civilian casualties in South Ossetia,” as reported by Russian federal TV channels."
Stem cell treatment not only allowed more horses to return to full duty and also greatly reduced the re-injury rate over a three-year period. The use of embryonic stem cells has also been applied to tendon repair. The embryonic stem cells were shown to have a better survival rate in the tendon as well as better migrating capabilities to reach all areas of damaged tendon. The overall repair quality was also higher, with better tendon architecture and collagen formed. There was also no tumor formation seen during the three-month experimental period. Long-term studies need to be carried out to examine the long-term efficacy and risks associated with the use of embryonic stem cells. Similar results have been found in small animals.
== Other activities == As an actress, Pansino appeared on Season 2 of VH1's Scream Queens, a reality series in which the prize was a role in one of the Saw films; she finished in 9th place. Following this, Pansino appeared in small roles on shows such as Parks and Recreation and CSI: Crime Scene Investigation. She voiced the role of Violet in the animated web series Broken Quest in 2013. In 2015, she made a cameo in the music video for "Dessert" by Dawin ft. Silentó. In 2016, she had a recurring voice role on the television series Emo Dad and also guest starred in the Disney Channel series Bizaardvark as herself. Pansino starred on the third season of YouTube Red's Escape the Night as The Jetsetter in 2018, the fourth season as The Socialite in 2019, and the later three-episode follow-up series as The Fitness Instructor in 2025. Pansino and the rest of the cast for both the third and fourth seasons were nominated for Streamy Awards. In 2023, she guest starred as a wedding planner on NCIS: Los Angeles, which she described as a "dream come true." Pansino is a classically trained singer. She released her debut single entitled, "Perfect Together", in 2015. Produced by Kurt Hugo Schneider, it was initially released as a single on iTunes, but a music video was released later the same year; as of 2019, it has over 20 million views. She has continued to post covers of popular songs on her YouTube channel, notably of songs like "Part of Your World" from the Disney movie The Little Mermaid.
The United Nations High Commission for Refugees rejects the comments. Dr Mike McKean, vice-president for policy at the Royal College of Paediatrics and Child Health, says that public health messaging suggesting vaping is 95% safer than smoking is ineffective as a growing number of children are using e-cigarettes and experiencing health problems, and that messaging should have made it clearer that vaping should be for adults trying to give up smoking. Five Bulgarian nationals accused of being part of a Russian spy ring appear in court in central London and are remanded in custody. 27 September The Rosebank oil and gas field off Shetland, the UK's largest untapped oil field, is granted consent by regulators, amid widespread concerns over its contribution to climate change. GB News suspends Laurence Fox as a presenter while it investigates comments he made on the channel about Ava Evans, a female journalist. Later in the day, Dan Wootton is suspended over the same incident. The UK's first drugs consumption room gets the go-ahead in Glasgow, allowing heroin and cocaine addicts to use the substances under supervision. A report by the Education Select Committee draws attention to the increased number of absences from schools in England, which has doubled since the COVID-19 pandemic; data for 2022–23 shows an average of 22.3% of school pupils were absent, compared to between 10% and 12% in the years prior to the pandemic. A combination of mental health issues and the cost of living crisis are attributed to the increase.
Sources: en.wikipedia.org
=== Whole-mass determination === The protein’s whole mass is the sum of the masses of its amino-acid residues plus the mass of a water molecule and adjusted for any post-translational modifications. Although proteins ionize less well than the peptides derived from them, a protein in solution may be able to be subjected to ESI-MS and its mass measured to an accuracy of 1 part in 20,000 or better. This is often sufficient to confirm the termini (thus that the protein’s measured mass matches that predicted from its sequence) and infer the presence or absence of many post-translational modifications.
=== Tolerance dose === In 1931, the U.S. Advisory Committee on X-Ray and Radium Protection (ACXRP, now the National Council on Radiation Protection and Measurements, NCRP), founded in 1929, published the results of a study on the so-called tolerance dose, on which a scientifically based radiation protection guideline was based. Exposure limits were gradually lowered. In 1936 the tolerance dose was 0.1 R/day. The unit "R" (the X-ray) from the CGS unit system has been obsolete since the end of 1985. Since then, the SI unit of ion dose has been "coulomb per kilogram".
In the first step of peptidoglycan synthesis, glutamine, which is an amino acid, donates an amino group to a sugar, fructose 6-phosphate. This reaction, catalyzed by EC 2.6.1.16 (GlmS), turns fructose 6-phosphate into glucosamine-6-phosphate. In step two, an acetyl group is transferred from acetyl CoA to the amino group on the glucosamine-6-phosphate creating N-acetyl-glucosamine-6-phosphate. This reaction is EC 5.4.2.10, catalyzed by GlmM. In step three of the synthesis process, the N-acetyl-glucosamine-6-phosphate is isomerized, which will change N-acetyl-glucosamine-6-phosphate to N-acetyl-glucosamine-1-phosphate. This is EC 2.3.1.157, catalyzed by GlmU. In step 4, the N-acetyl-glucosamine-1-phosphate, which is now a monophosphate, attacks UTP. Uridine triphosphate, which is a pyrimidine nucleotide, has the ability to act as an energy source. In this particular reaction, after the monophosphate has attacked the UTP, an inorganic pyrophosphate is given off and is replaced by the monophosphate, creating UDP-N-acetylglucosamine (2,4). (When UDP is used as an energy source, it gives off an inorganic phosphate.) This initial stage, is used to create the precursor for the NAG in peptidoglycan. This is EC 2.7.7.23, also catalyzed by GlmU, which is a bifunctional enzyme. In step 5, some of the UDP-N-acetylglucosamine (UDP-GlcNAc) is converted to UDP-MurNAc (UDP-N-acetylmuramic acid) by the addition of a lactyl group to the glucosamine. Also in this reaction, the C3 hydroxyl group will remove a phosphate from the alpha carbon of phosphoenolpyruvate.
=== Borderline personality disorder === Main section: § Borderline personality disorder Recent epigenetic findings suggest that KOR antagonists, which block the hyperactive KOR system, might be a viable pharmacological approach for borderline personality disorder (BPD) treatment, particularly for anhedonia, suicidality, and dissociative symptoms. Current early evidence supports the efficacy of naltrexone and nalmefene in reducing suicidal ideation, non-suicidal self-injury, binge eating, and dissociation in patients with BPD.
Avalglucosidase alfa, sold under the brand name Nexviazyme, is an enzyme replacement therapy medication used for the treatment of glycogen storage disease type II (Pompe disease). The most common side effects include headache, fatigue, diarrhea, nausea, joint pain (arthralgia), dizziness, muscle pain (myalgia), itching (pruritus), vomiting, difficulty breathing (dyspnea), skin redness (erythema), feeling of "pins and needles" (paresthesia) and skin welts (urticaria). Avalglucosidase alfa was approved for medical use in the United States in August 2021, and in the European Union in June 2022.
Sources: en.wikipedia.org
Sulfuric acid is capable of causing very severe chemical burns, especially when it is at high concentrations. In common with other corrosive acids and alkali, it readily decomposes proteins and lipids through amide and ester hydrolysis upon contact with living tissues, such as skin and flesh. In addition, it exhibits a strong dehydrating property on carbohydrates, liberating extra heat and causing secondary thermal burns. Accordingly, it rapidly attacks the cornea and can induce permanent blindness if splashed onto eyes. If ingested, it damages internal organs irreversibly and may even be fatal. Personal protective equipment should hence always be used when handling it. Moreover, its strong oxidizing property makes it highly corrosive to many metals and may extend its destruction on other materials. Because of such reasons, damage caused by sulfuric acid is potentially more severe than that by other comparable strong acids, such as hydrochloric acid and nitric acid.
=== Cuban linkage and "Namibianisation" === During his final years in office, Vorster had recognised that growing international pressure would eventually force South Africa to grant some form of autonomy or independence to South West Africa. He made token acknowledgements of the UN's role in deciding the territory's future and his administration had publicly renounced the notion of annexation. As Vorster's successor, Botha felt bound by this commitment—at least in principle—to an autonomous South West Africa. His strategy was to cultivate a viable political alternative to SWAPO, preferably moderate and anti-communist in nature, which was committed to close military and security links with South Africa. In the meantime, Botha forestalled further discussions on an internal settlement by demanding the withdrawal of the Cuban armed forces from Angola as a precondition of Namibian independence. Botha argued that the Cuban presence in Angola constituted a legitimate security concern for South West Africa, so it was not unreasonable that independence be contingent on a prior Cuban withdrawal. This initiative was supported by the US, which wanted a Namibian settlement consistent with Western interests, namely a region free of what Chester Crocker termed "Soviet-Cuban military adventurism". Crocker endorsed the linkage since it was related to South West Africa's security situation, which needed to be stabilised prior to independence. Botha's precondition was denounced by SWAPO for arbitrarily tying South West Africa's fate to the resolution of another regional conflict.
Indoor air quality is linked inextricably to outdoor air quality. The Intergovernmental Panel on Climate Change (IPCC) has varying scenarios that predict how the climate will change in the future. Climate change can affect indoor air quality by increasing the level of outdoor air pollutants such as ozone and particulate matter, for example through emissions from wildfires caused by extreme heat and drought. Numerous predictions for how indoor air pollutants will change have been made, and models have attempted to predict how the forecasted IPCC scenarios will vary indoor air quality and indoor comfort parameters such as humidity and temperature. The net-zero challenge requires significant changes in the performance of both new and retrofitted buildings. However, increased energy efficient housing will trap pollutants inside, whether produced indoors or outdoors, and lead to an increase in human exposure.
== Awards == Hunt has been awarded several honors including the Distinguished Contribution Award from the American Society for Mass Spectrometry in 1994; the Christian B. Anfinsen Award from the Protein Society; the Chemical Instrumentation Award and Field and Franklin Award from the American Chemical Society; the Thomson Medal from the International Mass Spectrometry Society; the Human Proteome Organization's Distinguished Achievement Award in Proteomics, and the Association of Biomolecular Resource Facilities 2007 Award. In addition, he also received the Charles H. Stone Award (American Chemical Society) and the Pehr Edman Award for outstanding achievements in the application of mass spectrometry. He received the Chemical Instrumentation Award sponsored by the American Chemical Society in 1997.
Sources: en.wikipedia.org
It is a synthetic pentapeptide in the growth hormone secretagogue family and acts as an agonist at the ghrelin receptor. It is handled as a laboratory research compound rather than a naturally occurring hormone.
Studies generally report growth hormone as the dominant output, with smaller or absent effects on adrenocorticotropic hormone and prolactin. The size of that separation depends on the assay and the dose examined, so it is best described as relative selectivity.
No natural source has been identified, and the molecule is produced by chemical synthesis. Its non-natural residues distinguish it from endogenous ghrelin even though both engage the same receptor.
It acts on the growth hormone secretagogue receptor, GHS-R1a, which is also the receptor for ghrelin. Binding triggers intracellular signaling that promotes growth hormone release from the pituitary. The interaction is the basis for its classification as a secretagogue.